Vivoryon Therapeutics N.V.Vivoryon Therapeutics N.V.Vivoryon Therapeutics N.V.

Vivoryon Therapeutics N.V.

No trades
See on Supercharts

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Description
Event date
Documents and forms
2025
Q2 2025
Sep 4, 2025
Interim report
Slides
Transcript
Q1 2025
Jun 17, 2025
Earnings release
Slides
Transcript
Corporate Presentation
May 13, 2025
Slides
Status Update
Feb 18, 2025
Slides
2024
H2 2024
Apr 29, 2025
Interim report
Slides
Transcript
Q3 2024
Dec 10, 2024
Report
Slides
Corporate Presentation
Nov 20, 2024
Slides
Status Update
Sep 30, 2024
Press release
H1 2024
Sep 12, 2024
Interim report
Slides
R&D Update
Jul 18, 2024
Slides
Q1 2024
May 23, 2024
Interim report
2023
H2 2023
Apr 24, 2024
Earnings release
Slides
Q3 2023
Dec 6, 2023
Interim report
Slides
Investor Presentation
Oct 10, 2023
Slides
H1 2023
Sep 7, 2023
Interim report
Slides
Q1 2023
May 16, 2023
Interim report
2022
H2 2022
Apr 19, 2023
Annual report
Slides
Q3 2022
Nov 22, 2022
Interim report
Slides
H1 2022
Sep 30, 2022
Interim report
Slides